Orlando, FL (PRWEB) January 04, 2013
The prescription drug resource center DrugRisk.com has added information to its comprehensive Yaz database which may indicate how long the current settlements for blood clot injury claims may last in 2013.
The goal of DrugRisk is to improve public safety through education of the latest prescription drug warnings, recalls, studies and litigation news. “In the case of the ongoing Yaz settlements, we felt it important that patients know the timeline set by court officers,” said DrugRisk representative Ryan Mayer.
DrugRisk recently added new health warnings for Yaz from the American College of Obstetricians and Gynecologists, who advised that birth control pills containing drospirenone, such as Yaz and Yasmin, may have a higher risk of causing blood clots.*
The resource center also contains information about the Yaz lawsuits which have been consolidated to a special federal Multi-District Litigation court in Illinois. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).
DrugRisk recently learned that Bayer, who makes Yaz and Yasmin, disclosed that they have settled approximately 3,500 Yaz lawsuits involving blood clot injuries so far for a total cost of nearly $750 million.** These include conditions like stroke, deep vein thrombosis and pulmonary embolism.
Now, the resource center is advising patients that the court officer appointed to oversee settlement negotiations for the federal court, special master Stephen Saltzburg, estimated in July that the Yaz settlements could be concluded within a year, which would put a deadline around summer of 2013.
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.
The Drug Risk Resource Center cautions victims who wish to learn about their legal options that they should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.
For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.
*Chicago Tribune October 24, 2012, “Newer Pill has low blood clot risk: ob-gyn group”
**Bayer Interim Financial Statement, Legal Notes and Business Development, September 30, 2012